Skip Navigation

European Heart Journal 2000 21(19):1566-1567; doi:10.1053/euhj.2000.2271
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Grant, P.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grant, P.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorial

The Edinburgh Artery Study: is lytic activity bad for the heart?

P.J. Grant

Academic Unit of Molecular Vascular Medicine, The General Infirmary, Leeds, U.K.

References

  1. Smith FB, Fowkes FGR, Rumley A, Lee AJ, Lowe GDO, Hau CM. Tissue plasminogen activator and leucocyte elastase as predictors of cardiovascular events in subjects with angina pectoris: Edinburgh Artery Study. Eur Heart J. 2000;21:1607–1613[Abstract/Free Full Text]
  2. Thompson SG, Kienast J, Pyke SDM, Haverkate F, Van De Loo J. Haemostatic factors and the risk of myocardial infarction or sudden death in patients with myocardial infarction. N Engl J Med. 1995;332:635–641[Abstract/Free Full Text]
  3. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet. 1993;341:1165–1168[CrossRef][Web of Science][Medline]
  4. Lowe GDO, Yarnell JWG, Sweetnam PM, Rumley A, Thomas HF, Elwood PC. Fibrin D-Dimer, tissue plasminogen activator, plasminogen activator inhibitor and the risk of major ischaemic heart disease in the Caerphilly Study. Thromb Haemost. 1998;79:129–133[Web of Science][Medline]
  5. Ridker PM, Hennekens CH, Cerskus A, Stampfer MJ. Plasma concentration of cross-linked fibrin degradation product (D-dimer) and the risk of future myocardial infarction among apparently healthy men. Circulation. 1994;90:2236–2240[Abstract/Free Full Text]
  6. Morrison HM, Welgus HG, Owen CA, Stockley RA, Campbell EJ. Interaction between leukocyte elastase and elastin: quantitative and catalytic analyses. Biochim Biophys Acta. 1999;1430:179–190[CrossRef][Medline]
  7. Stockley RA. New approaches to the management of COPD. Chest. 2000;117:58S–62S[Abstract/Free Full Text]
  8. Knight KR, Burdon JG, Cook L, Brentonr S, Ayad M, Janus ED. The proteinase-antiproteinase theory of emphysema: a speculative analysis of recent advances into the pathogenesis of emphysema. Respirology. 1997;2:91–95[Medline]
  9. Blann AD, Seigneur M, Adams RA, McCollum CN. Neutrophil elastase, von Willebrand factor, soluble thrombomodulin and percutaneous oxygen in peripheral atherosclerosis. Eur J Vasc Endovasc Surg. 1996;12:218–222[CrossRef][Web of Science][Medline]
  10. Tiefenbacher CP, Ebert M, Niroomand F. Inhibition of elastase improves myocardial infarction after repetitive ischaemia and myocardial infarction in the rat heart. Eur J Physiol. 1997;433:563–570[CrossRef][Web of Science][Medline]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 ANGIOLOGYHome page
L. H. Reisin, N. Pancheva, M. Berman, V. Khalameizer, J. Jafary, C. Yosefy, Y. Blaer, I. Manevich, R. Peled, and S. Scharf
Circadian Variation of the Efficacy of Thrombolytic Therapy in Acute Myocardial Infarction--Isn't the Time Ripe for Cardiovascular Chronotherapy?
Angiology, May 1, 2004; 55(3): 257 - 263.
[Abstract] [PDF]

Home page
 Eur Heart JHome page
P. Fernandez, P. Marco, F. Marin, V. Roldan, and F. Sogorb
The role of tissue plasminogen activator on the progression of the coronary disease
Eur. Heart J., January 1, 2002; 23(1): 88 - 88.
[Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (2)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Grant, P.J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Grant, P.J.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?